TrialEMBO molecular medicine2016

Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies.

Jérémie Decalf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.